growth

profile

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

$AVXL is expected to show quite a strong growth in EPS.

$AVXL is expected to show a strong growth in EPS.

$PDD closed 12.62% higher on Monday after the company reported a 65% year-over-year growth in its third-quarter revenue.

“Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023”
Oh, 48 weeks! !

Anavex said that the candidate&#39;s safety profile also appeared to be relatively good.

Anavex also better in ADAS-Cog14, and far superior safety profile.

&gt;&gt; no clinically significant treatment-related adverse events and no serious adverse events = PERFECT SAFETY PROFILE !!

with Blarcamesine&#39;s outstanding safety profile this will become the #1 off label prescribed drug in the world.

$AVXL for Hans, 

yes $avxl is great and will get approved when it’s high dose arm absolutely crushes the current SOC with a flawless safety profile.

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

Biocryst Pharmaceuticals Inc.

trading

$XBI $BCRX XBI trading at 2017 prices holy fuck

$BCRX Jon should have been investigated for insider trading and his pulled offering and his many many misleading statements of embezzlement of riches!

Don’t fall for their bullshit, let the dogs trade with themselves

Big Loser Alert: Trading today&#39;s -8.4% move in BIOCRYST PHARMACEUTICALS $BCRX https://wp.me/p5bLGB-iCRZ

You might have lost money on every trade and every move.

but the trading, at least in my mind, seems a bit strange, and a bit like its percolating,  and something is brewing, such as 9930 prelim data, or some other pr drop is coming.

$BCRX the options pricing on this ticker trading in five cent increments really chaps my ass.

Shorting like this should be 100% illegal in my opinion and falls under manipulation of fair trading!

executive

$BCRX  
 
man ceo scamhouse sucks royal ass 
 
lying prick 
 
💩💩💩💩💩

too bad $bcrx has that chicken shit ceo scamhouse.

if anyone in $xbi $ibb are looking for a bio with a pos lying scumbag ceo then look at 
 
$BCRX 
 
one of the worst anywhere 
 
thank me later

Board needs to act as ceo has mislead his shareholders deceitful action!

Your CEO and board are lightweight morons and your shares will continue to lose value.

$BCRX “what’s the value of that” - Jack shit When You’re CEO

Your CEO and board are fucking idiots who had a solid hand

Their fucking shares are underwater because you’re a shit CEO

premium

We have no premium because Stoney is a dumb cunt.

NOW EVEN WITH NEARLY 300M IN FUCKING REVS THESE WORTHLESS FUCKS ON THE BOD CANT GET ANYTHING DONE EXCEPT SPEND TONS OF CASH ON USELESS SHIT PROGRAMS IN THE PIPE INSTEAD OF MAKING US PROFITABLE WITH WHAT THEY HAVE AN SELLING AT A PREMIUM.

but saw the .47/per - even higher premium than my $13s!

$BCRX disappointing price action over the last 3 days, the only reason why this doesn’t bother me so much is the call premium!

$BCRX Took a 50k loss, I’m the fuck outta here.

You played people here all while you lined your pocket with their losses!

$BCRX For the first time in over 2 years I might be setting a stop loss on my remaining position, dang it

$BCRX Investing in Biotech should come with a WARNING:
Will cause hair loss, vomiting, Insomnia and alcohol addiction lol

When it’s bad, it’s very bad.

That is a loss of just 18 to 19% for a VERY volatile bio market sector in a historically VERY shitty bear market.

$BCRX looks like EOY will not be very good.. 13,75 it was 31-12-2021.. now we are at 10,65.. looks like 2022 will end with a pretty big YTY loss

$BCRX this stock is as frustrating as that Spain loss 😤

Carvana swung to an adjusted operating loss of $186 million compared to a $9 million profit a year ago.

YOU MORONS HAVEN’T DONE YOUR JOB THE PAST 2 YEARS IN FORCING STONEHOUSE’S HAND FOR A BUYOUT.

Or sell the damn company and let a real Pharma with real leadership do the job.

Btw they are doing a crappy job trying to play up the new compound, cuz it’s to early.

$BCRX damn its like they knew i was gone and didn&#39;t do SHIT jobs wise

Time to buy these growth stocks like $pacb nvta $adma $bcrx

$BCRX is expected to show a strong growth in EPS.

$BCRX The biggest props to @Sandeman52 for having the balls to pivot from a position he was holding here for years to another stock that looks great and has a great growth story in the making and sharing it in real time.

We have a revenue generating drug thats just achieved 105% YoY growth.

$BCRX 10% growth quarter over quarter considering flat q1 (as noted with ins payout sched) puts us at 326mil for the year.

&quot;We believe BCX10013 has the potential to be a best-in-class treatment option with an oral, once-daily profile,”

$BCRX This is actually a good buy at these levels.

data

$BCRX  
European stocks rose on Friday as investors took an optimistic view of a week of data releases that showed economies in Europe and the US were more robust than expected.

#1 Suddenly alot of positive accounts appear, promoting the company has solid data, solid sales

$BCRX Have strong feeling once 10013 data is out we are going places.

$BCRX This preliminary data on BCX10013 is pretty impressive.

$BCRX great 10013 data and 320+ projected rev

but it also seems like the good choice to do so seeing iptacopan data.

Long term Bcrx should climb quarter after quarter until they align with projections billion plus!

Positive news with the early results of the new Factor D molecule 10013.

Relative strength to SPY past 6 weeks, high growth 8 quarters straight.

$BCRX 10.5 is the new high for this first quarter.

$BCRX so they hit their Q4 numbers, had stellar phase IA results and guided for a 70Mil increase in revenue in 202e.

$BCRX sales doubled 4 quarter 70.7 million + 53% year over year..

Result - volume up about 36.5% over a normal day.

But, with our management, our scientists, and our derisked ORLADEYO keeping the revenues incoming and growing quarter after quarter after quarter.

Prem results in q1 and it will beat any drug in the mkt.

Baudax Bio Inc

crash

$BXRX This is like a bloody car crash - I cannot look away.

flow

Money flow now &quot;extreme bearish.&quot;

management

BXRX management and BOD are the definition of FAILURE!!

$BXRX Watching all the new bulls here compared to a month ago, some of you will end up bag holding this for a long time.. this company has some of the most selfish management in the entire market.

This can only be due to fraudulent practices on the part of Baudax Bio management, such as misrepresenting the market potential of Anjeso, lying about the CEO&#39;s credentials, colluding with short sellers, etc.

i’ve watched it for years.. nothing good ever happens with management

Stay far, far away from this toxic stock, company and management.

but that this  company is allowed to continue to serve as an ATM for management, while fleecing investors, is an absolute travesty.

BXRX management should be in jail for what they did to this company.

Company has no viable products, no revenue, incompetent, self-dealing management, multiple dilutions and reverse splits.

split

Look at all the reverse splits in this turd.

$BXRX fucking turds, two splits in one year, Good lord.

$BXRX  😂😂 and yet another split on the way,  what a horrific stock.

A 1 for 40 reverse stock split and an immediate dilution/stock offering……..in other words………a savage ass pounding without even a cigarette break.

stop

but this thang don’t stop tumbling down the mountain

$BXRX is expected to show quite a strong growth in EPS.

I couldn&#39;t be more excited for our continued growth and success together in 2023!

A competitor to Hubspot with excellent management and a massive growth runway.

news

$ENSC big news coming in days ahead,  very cheap.

Mid day top percent stock gainers on news and/or vol.

$INPX $BIAF $GROM $BXRX $COSM  very strong holding  above 1.90 that great news for tomorrow

We are the only low float good news stock today.

Analysts have set a price target of $3 for ENSC&#39;s stock, making it a strong buy for those looking to invest in the future of the industry🔥🚀 
 
Also following: 
$THMO $HUBC $TRKA $BXRX

$REVB More and More buys from all over the market are entering here now.

$INPX volume swelling on buys coming in locking it up
$BXRX go bulls!

🚨   $SPRC This could be the greatest buy in small caps right now or at least one of them.

Prty more up, cosm $4 buy spot,  Htgm filling premarket, slapping in 🔥

hold

$BXRX Long term hold for me PT 10 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

.It will move on thin air 
$sidu is a nice hold 
$boxd nice volume.

$BXRX Once again bulls prove they can&#39;t hold shit

$BXRX as long as it holds the VWAP it is still bullish.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Mar, 20, 2023

Mar, 18, 2023

BCRX

Biocryst Pharmaceuticals Inc.

-23.50%

$10.68 - $8.17

Mar, 20, 2023

Feb, 19, 2023

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Feb, 8, 2023

Dec, 29, 2022

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Mar, 20, 2023

Mar, 18, 2023

Feb, 26, 2023

Nov, 29, 2022

BCRX

Biocryst Pharmaceuticals Inc.

-23.50%

$10.68 - $8.17

Mar, 20, 2023

Feb, 19, 2023

Feb, 9, 2023

Feb, 7, 2023

Feb, 3, 2023

Jan, 16, 2023

Jan, 13, 2023

Jan, 9, 2023

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Feb, 8, 2023

Dec, 29, 2022

Dec, 21, 2022

Dec, 20, 2022